• Complain

Michael D. Green - Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation

Here you can read online Michael D. Green - Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation full text of the book (entire story) in english for free. Download pdf and epub, get meaning, cover and reviews about this ebook. year: 1998, publisher: University of Pennsylvania Press, genre: Romance novel. Description of the work, (preface) as well as reviews are available. Best literature library LitArk.com created for fans of good reading and offers a wide selection of genres:

Romance novel Science fiction Adventure Detective Science History Home and family Prose Art Politics Computer Non-fiction Religion Business Children Humor

Choose a favorite category and find really read worthwhile books. Enjoy immersion in the world of imagination, feel the emotions of the characters or learn something new for yourself, make an fascinating discovery.

No cover
  • Book:
    Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation
  • Author:
  • Publisher:
    University of Pennsylvania Press
  • Genre:
  • Year:
    1998
  • Rating:
    5 / 5
  • Favourites:
    Add to favourites
  • Your mark:
    • 100
    • 1
    • 2
    • 3
    • 4
    • 5

Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation: summary, description and annotation

We offer to read an annotation, description, summary or preface (depends on what the author of the book "Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation" wrote himself). If you haven't found the necessary information about the book — write in the comments, we will try to find it.

Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drugs manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system.

Michael D. Green: author's other books


Who wrote Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation? Find out the surname, the name of the author of the book and a list of all author's works by series.

Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation — read online for free the complete book (whole text) full work

Below is the text of the book, divided by pages. System saving the place of the last page read, allows you to conveniently read the book "Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation" online for free, without having to search again every time where you left off. Put a bookmark, and you can go to the page where you finished reading at any time.

Light

Font size:

Reset

Interval:

Bookmark:

Make
title Bendectin and Birth Defects The Challenges of Mass Toxic - photo 1

title:Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation
author:Green, Michael D.
publisher:University of Pennsylvania Press
isbn10 | asin:0812216458
print isbn13:9780812216455
ebook isbn13:9780585330198
language:English
subjectProducts liability--Drugs--United States, Toxic torts--United States, Complex litigation--United States, Bendectin (Trademark)--Toxicology, Abnormalities, Human.
publication date:1996
lcc:KF1297.D7G74 1996eb
ddc:346.7303/8
subject:Products liability--Drugs--United States, Toxic torts--United States, Complex litigation--United States, Bendectin (Trademark)--Toxicology, Abnormalities, Human.
Page iii
Bendectin and Birth Defects
The Challenges of Mass Toxic Substances Litigation
Michael D. Green
Page iv Copyright 1996 by the University of Pennsylvania Press All rights - photo 2
Page iv
Copyright 1996 by the University of Pennsylvania Press
All rights reserved
Printed in the United States of America
Library of Congress Cataloging-in-Publication Data
Green, Michael D., 1950
Bendectin and birth defects : the challenges of mass toxic
substances litigation / Michael D. Green.
p. cm.
Includes bibliographical references and index.
ISBN 0-8122-3257-7 (alk. paper)
1. Products liabilityDrugsUnited States. 2. Toxic torts
United States. 3. Complex litigationUnited States.
4. BendectinToxicology. 5. Abnormalities, Human. I. Title.
KF1297.D7G74 1996
346.7303'8dc20 95-42306
[347.30638] CIP
Page v
To my children,
ABBY, BRETT, and ROSS
for whom I am endlessly grateful
Page vii
Contents
Preface
ix
Acknowledgments
xi
1
A Birth Defect Child Is Born
1
2
Locating Bendectin within the Mass Toxic Landscape
4
3
The Science of Determining Toxic Causation
26
4
The Food and Drug Administration
44
5
The Wm. S. Merrell Company
61
6
A Mother's Quest
96
7
The Mekdeci Case
121
8
The Unraveling of Mekdeci
148
9
The Proliferation of Bendectin Litigation
159
10
Litigating a Multidistrict Case
167
11
The Withdrawal of Bendectin
180
12
Forging a Mass Toxic Substances Trial
189
13
The Settlement and Unsettlement of MDL-486
207
14
The MDL-486 Trial
226
15
Aggregative Procedure in Mass Toxic Substances Litigation
237
16
The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials
273
17
The Legacy of Bendectin for Toxic Causation Law
299
18
The Lessons and Non-Lessons of Bendectin Litigation
328
Selected Bibliography
353
Index
361

Page ix
Preface
When Bendectin litigation first emerged, with allegations that it caused birth defects, I was a young law professor who was teachingand learningproducts liability law. I took notice of the litigation as well because a dear friend had suffered from severe morning sickness during her first pregnancy, and I knew that she had used Bendectin to help quell her nausea and vomiting. The emerging concerns about birth defects posed a quandary for me as to whether I should alert my friend about these developments during her next pregnancy. I chose the uncourageous path, consoling myself that I really didn't know whether there was any truth to the claims.
Later, in the mid-1980s, while working on a Products Liability casebook, I was reading Bendectin cases that reached conflicting outcomes, which further piqued my curiosity. How could these cases be resolved differently? What was the situation with regard to the evidence of Bendectin's connection with birth defects? The early stages of asbestos litigation had been characterized by similar differing results, and I decided that it might be interesting to investigate Bendectin litigation. I was lucky enough to have a job that permitted me to do so. Around that time, Peter Schuck published his splendid account of the Agent Orange litigation and that book served as a model for my effort. Schuck's work stands as a standard for an increasing number of in depth chronicles of prominent case congregations.
Next page
Light

Font size:

Reset

Interval:

Bookmark:

Make

Similar books «Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation»

Look at similar books to Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation. We have selected literature similar in name and meaning in the hope of providing readers with more options to find new, interesting, not yet read works.


Reviews about «Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation»

Discussion, reviews of the book Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation and just readers' own opinions. Leave your comments, write what you think about the work, its meaning or the main characters. Specify what exactly you liked and what you didn't like, and why you think so.